相关实验视频

Updated: Jul 16, 2025

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Repression of Multiple Myeloma Cell Growth In Vivo by Single-wall Carbon Nanotube SWCNT-delivered MALAT1 Antisense Oligos

Published on: December 13, 2018

微RNA和多发性髓瘤:专注于病变发生,预后和耐药性

Ali Tavakoli Pirzaman¹, Pouyan Ebrahimi¹, Amir Hossein Hasanpour¹

¹Student Research Committee, Babol University of Medical Sciences, Babol, Iran.

Technology in cancer research & treatment

|September 20, 2023

概括

微RNAs (miRNAs) 是多发性骨髓瘤 (MM) 发展和耐药性的关键调节者. 了解miRNA签名为诊断,预后和治疗这种血液癌症提供了潜力.

科学领域:

血液学血液学血液学
分子生物学分子生物学
在瘤学瘤学.

背景情况:

多发性骨髓瘤 (MM) 是一种显著的血液性恶性瘤,其特征是克隆性血细胞和单克隆性抗体的积累.
乳腺癌占所有癌症的1%,血液恶性瘤的13%,需要先进的诊断和治疗策略.
微RNAs (miRNAs) 是简短的非编码RNAs,调节基因表达,并与癌症的发展和耐药性有关.

研究的目的:

审查miRNA研究中的最新进展,关于它们在多发性骨髓瘤中的作用.
探索miRNA签名在MM患者的诊断,预后和指导治疗反应方面的潜力.

主要方法:

关于微RNA和多发性髓瘤的当前科学文献的综述.
在MM患者的血细胞中研究miRNA表达水平.
分析开发的工具,以评估miRNAs对瘤生长的影响.

主要成果:

miRNAs在多发性骨髓瘤的发病,进展和治疗耐药性中发挥着至关重要的作用.
在MM患者中miRNA分析显示出用于诊断和预后应用的前景.
正在研究特定的miRNA特征,以确定它们对髓瘤细胞增殖的直接影响.

结论:

微RNA研究对于理解多发性骨髓瘤至关重要.
基于miRNA的诊断和治疗具有改善MM患者治疗结果的巨大潜力.
未来的研究应该专注于验证和将miRNA发现转化为MM管理的临床实践.

关键词:

药物耐药性耐药性药物耐药性这是一个小RNARNA.多发性骨髓瘤是多发性骨髓瘤的一种.病变的发生和发病.预后预后预后

更多相关视频

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice

Published on: January 7, 2019

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

miRNA Expression Analyses in Prostate Cancer Clinical Tissues

Published on: September 8, 2015

相关概念视频

MicroRNAs

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Abnormal Proliferation

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...